Get started
Author

Maria Vladimirovna Barabanshikova

Observed names: Barabanshikova, M.V., M. Barabanshikova, Maria Barabanshikova, Maria V. Barabanshikova, Maria Vladimirovna Barabanshikova
OpenAlex ID: A5007928201
A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
2020 · Elena Vladislavovna Morozova, Maria Vladimirovna Barabanshikova, et al. · Acta Haematologica · 41
Splenectomy following JAK1/JAK2 inhibitor therapy in patients with myelofibrosis undergoing allogeneic stem cell transplantation
2019 · Maria Vladimirovna Barabanshikova, Igor Nikolaevich Zubarovsky, et al. · Hematology/Oncology and Stem Cell Therapy · 15
Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome
2020 · Nikolai Tcvetkov, Artem Gusak, et al. · Leukemia Research Reports · 14
PDF
Clinical Correlates and Prognostic Significance of IL-8, sIL-2R, and Immunoglobulin-Free Light Chain Levels in Patients with Myelofibrosis
2017 · Maria V. Barabanshikova, Irina A. Dubina, et al. · Oncology Research and Treatment · 12
Thrombopoietin receptor agonists for treatment of poor graft function after allogeneic hematopoietic stem cell transplantation in adults
2019 · Tatiana A. Rudakova, Alexander D. Kulagin, et al. · Cellular Therapy and Transplantation · 7
PDF
High mutation burden in the checkpoint and micro-RNA processing genes in myelodysplastic syndrome
2021 · Ivan Sergeevich Moiseev, Nikolay Yurevich Tcvetkov, et al. · PLoS ONE · 6
PDF
Profile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome
2020 · Nikolai Yu. Tcvetkov, Elena V. Morozova, et al. · Blood · 5
First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens
2022 · Ivan Moiseev, Maria Barabanshikova, et al. · Bone Marrow Transplantation · 4
Application of standard and novel prognostic systems in patients with myelodys- plastic syndrome undergoing allogeneic hematopoietic stem cell transplantation
2019 · Elena V. Morozova, Maria V. Barabanshikova, et al. · Cellular Therapy and Transplantation · 2
PDF
Graft-Versus-Host Disease Prophylaxis with Posttransplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
2017 · Еlena V. Morozova, Ivan S. Moiseev, et al. · Blood · 2
Mutations in DICER1 and DROSHA genes: a rare event in myelodysplastic syndromes and acute myeloid leukemia
2025 · Maria Barabanshikova, Dmitrii Bug, et al. · Cellular Therapy and Transplantation · 1
Salvage second allogeneic stem cell transplantation for primary and secondary graft failure in adult patients
2023 · Tatiana Rudakova, Ekaterina Yakimenko, et al. · Cellular Therapy and Transplantation · 1
PDF
Transition from the smoldering systemic mastocytosis to chronic mast cell leukemia: a clinical case
2022 · Zarema Abdulkhalikova, Ildar Barkhatov, et al. · Cellular Therapy and Transplantation · 1
PDF
The Outcome of Patients with Advanced Phase Chronic Myeloid Leukemia with and without Allogeneic Hemopoietic Stem Cell Transplantation
2020 · Elena V. Morozova, Julia J. Vlasova, et al. · Blood · 1
Ps1193 Characteristics and Outcomes of the Treatment Patients With T315i Mutation Cml
2019 · J. Vlasova, E. Morozova, et al. · HemaSphere · 1
Hematopoietic stem cell transplantation and other therapeutic options in primary myelofibrosis: a review and two case reports
2016 · Elena V. Morozova, Maria V. Barabanshikova, et al. · Cellular Therapy and Transplantation · 1
PDF
Management of splanchnic venous thrombosis after splenectomy in hematologic diseases: systematic review, meta-analysis, and consensus guidelines
2025 · Núria Lluís, Filipe Kunzler, et al. · International Journal of Surgery
Genetic landscape in the group of patients with lower-risk myelodysplastic neoplasms
2025 · Ksenia Tsvirko, Nikolay Tsvetkov, et al. · Cellular Therapy and Transplantation
The outcome of patients with advanced phase chronic myeloid leukemia with and without allogeneic hematopoietic stem cell transplantation
2020 · Elena Morozova, Yulia Vlasova, et al. · Cellular Therapy and Transplantation
PDF
Supplementary Material for: A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
2020 · Morozova, E.V., Barabanshikova, M.V., et al. · Figshare
A pilot study of ruxolitinib combined with cyclophosphamide for graft-versus-host disease prophylaxis and relapse prevention in patients with myelofibrosis: a prospective study
2018 · Maria V. Barabanshikova, Ivan S. Moiseev, et al. · Cellular Therapy and Transplantation
Posttransplant ruxolitinib combined with cyclophosphamide for graft versus host disease prophylaxis and relapse prevention in patients with myelofibrosis
2016 · Maria V. Barabanshikova, Ivan S. Moiseev, et al. · Cellular Therapy and Transplantation
PDF
Works count: 22
Citation count: 114
H-index: 6
I10-index: 4
Year
Topic
Type